TIBER CREEK GROUP for PHRMA
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 23, 2017 | $80,000 | Replaced |
| 4th Quarter - Amendment | Jan 24, 2017 | $80,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
IP and market access issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| JUSTIN MCCARTHY | — |
Health Issues HCR
Reforms to Medicare Part D. Patent settlements. Proposed Medicare and Medicaid cuts, including proposed cuts to Medicare Part D. HRSA program regarding rebates on drugs used in the outpatient setting to help low-income/uninsured populations (340B). Issues related to drug pricing. Issues relating to Medicare Part B reimbursement. Innovation/R&D. Issues related to Vice President's Moonshot Initiative. Issues related to drug pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| ANDREW MCKECHNIE | — |
| JENNIFER OLSON | — |
Medicare/Medicaid MMM
Reforms to Medicare Part D. Medicare fraud. Issues relating to Medicare Part B reimbursement. 21st Century Cures Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| ANDREW MCKECHNIE | — |
| JENNIFER OLSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.